# ASP1517 Pharmacokinetics Study in Anemia Patients on Hemodialysis

> **NCT01083888** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 12 (actual)

## Conditions studied

- Anemia
- Hemodialysis
- Renal Impairment

## Interventions

- **DRUG:** roxadustat

## Key facts

- **NCT ID:** NCT01083888
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02-15
- **Primary completion:** 2010-06-07
- **Final completion:** 2010-06-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01083888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01083888, "ASP1517 Pharmacokinetics Study in Anemia Patients on Hemodialysis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01083888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*